Your ongoing refusal to release these deals raises questions about whether the Trump administration is trying to hide the fact that it is giving billion-dollar handouts to Big Pharma without getting anything meaningful in return for Americans.
Critique of the Trump administration's drug pricing deals.
Share
More from Elizabeth Warren
The nation’s 1.2 million nursing home residents face unique problems in obtaining access to the voting booth.
The appearance of numerous conflicts of interest from a President trading in individual stocks – including the potential for insider trading, market manipulation, and policy decisions that benefit the President’s stock portfolio rather…
I urge Walmart, Target, and some major tech companies to translate tariff refunds into lower prices for shoppers.
(safety regulation rollbacks) were motivated solely by ideology it would reflect a dangerously bad set of policies by the Trump administration. But the specter of corruption – and quid pro quo politics – casts a darker shadow over these…
Other voices in this conversation
